Atlas FDA

NATRELLE® Saline-Filled Breast Implants

FDA premarket approval P990074/S053 · decided 2024-06-21

Approval details

PMA number
P990074
Supplement
S053
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
NATRELLE® Saline-Filled Breast Implants
Generic name
Prosthesis, breast, inflatable, internal, saline
Applicant
Allergan
Date received
2024-05-31
Decision date
2024-06-21
Days to decision
21 days
Decision code
OK30
Product code
FWM
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
The 30 Day notice is to notify FDA of the commissioning of the new MO675 RODI Process Water System in the Costa Rica facility

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25